AbCellera Biologics Inc.
ABCL· Nasdaq
Released Mar 29, 2021, after the close
10-K filed Mar 30, 2021, 89 days after period end · 0001564590-21-016713
derived · Computed from the longer spans the company filed.
no prior Q4 2019 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
AbCellera Biologics Inc. · CIK 1703057 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 30, 2021 · 89 d after period end
+14.6% from the close of Mar 29, 2021 to the close of Mar 30, 2021, the first after the release.